Senior sales leaders will oversee efforts to introduce an expanding product portfolio to a larger client base
SAN MATEO, Calif., Feb. 6, 2019 — Apixio Inc., a leading healthcare AI analytics company, today announced the promotion of two sales executives to senior positions. The Apixio team has grown by 40 percent last year and plans to grow by 40 percent again in 2019 after relocating its headquarters to larger offices in San Mateo. The company promoted Lou Steinberg to Senior Vice President, Payer Market Sales and Mark Hellewell to Vice President, Provider Market Sales. Steinberg and Hellewell will assume key leadership positions on the sales team as the company expands its market leadership position with payers and providers.
Lou Steinberg has served as Vice President of Sales at Apixio for the past five years. He has more than twenty years of experience in sales roles for healthcare organizations, including Optum and Peak Health. Under his leadership, the company continues to add some of the most recognized health insurance companies to its client roster.
“Over the past five years, I’ve watched Apixio grow to become a leader in healthcare analytics, and it’s exciting to see our solutions provide so much value to clients. I’m looking forward to helping the company continue to provide best-in-class products and client service in the coming years,” said Steinberg.
Mark Hellewell, a sales veteran with fifteen years of healthcare and technology experience, previously served as Vice President of Sales, Western Region, and has been with Apixio for five years. His work has directly contributed to the company’s rapid growth among health systems, and he has been critical to building and maintaining strong client relationships.
“Apixio’s products have gained great traction with risk-bearing providers in recent years. I’m honored to take on a more significant leadership role within the company and continue building our reputation as an excellent service partner in the provider space,” said Hellewell
Steinberg and Hellewell will continue to report to Tom McNamara, Chief Revenue Officer at Apixio.
Apixio, a leading healthcare AI analytics company, developed a patented machine learning data analysis platform to power value-based care by mining medical records and administrative data for novel patient insights. Apixio’s risk adjustment solution suite leverages proprietary algorithms to help organizations more accurately and efficiently evaluate patient risk for managed Medicare and commercial plans. Apixio’s exciting new quality measurement and clinical solutions will enable payers and providers to deliver optimal care.
Contact: Alyssa Marty, email@example.com